

A total of 43, 548 participants were observed for the safety and efficacy report of the Pfizer COVID-19 report and not a single patient demonstrated an isolated pulmonary embolism event. The literature states that a lot of patients that are having PE after mRNA vaccine also have associated thrombocytopenia, however, this is not what this patient demonstrates. Vaccination reports of pulmonary embolism are increasing, however, isolated PE without a DVT is still very underreported and rare.
:max_bytes(150000):strip_icc()/anemia-after-surgery-3156852-Final-63c258f51d7846e1b24d870a3b8ea88c.png)
Severe acute respiratory syndrome-coronavirus-2 has been proven to increase the risk of venous thromboembolism because it is a prothrombotic virus. Isolated PE in a young healthy patient was never reported as an adverse event from the Pfizer safety and efficacy report. Adverse events that were reported were shoulder injury, right axillary lymphadenopathy, paroxysmal ventricular arrhythmia, and right leg paresthesia. Many of the common side effects reported were pain at the injection site, fatigue, headache, and fever. Therefore, he was managed by Eliquis.ĭISCUSSION: Pfizer released a safety and efficacy report of the BNT162b2 mRNA Covid-19 Vaccine. CTA of chest was performed and revealed left-sided pulmonary emboli involving the left lower lobe with pulmonary infarction. Fibrinogen was elevated and hypercoagulable work-up was negative. Labs were stable and hemoglobin was stable throughout the hospital course. Physical examination revealed reduced breath sounds in the left lower lobe. He also states he has been coughing up a teaspoon amount of blood with this chest pain.

He describes it as constant sharp pain with varying intensity that he rates a 6/10 and can reach a 10/10 pain exacerbated with lying flat and deep breathing. He received the mRNA COVID-19 Pfizer vaccine 5 days prior to symptom onset. He denied any family history or personal history of clotting disorders. Unprovoked isolated pulmonary embolisms are rare.ĬASE PRESENTATION: A 24 year old male with no significant past medical history presented to the emergency department due to shortness of breath, hemoptysis and chest pain. Many side effects were unknown and discovered as time went on. Pfizer mRNA COVID-19 vaccine was granted emergency use by the FDA after proving efficacy in early trials. Companies were frantic to find a solution to help prevent so many unnecessary deaths. The healthcare system is going into a crisis facing a disease that is unknown and overwhelming. INTRODUCTION: The year of 2020 will be a year never forgotten when the COVID-19 pandemic began. SESSION TITLE: Variety in Risk Factors and Treatment of VTE
